OSMT Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Jan 2022 @ 06:00):

Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary...

Stats
Tagesvolumen	296 322
Durchschnittsvolumen	594 359
Marktkapitalisierung	110.18M
EPS	$-0.280 ( 2021-11-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.694
ATR14	$0.0990 (8.92%)

Insider Trading

Date	Person	Action	Amount	type
2021-01-24	Klein Christopher	Sell	9 605	Ordinary Shares
2020-05-20	Cowan Gregory L	Buy	38 716	Ordinary Shares
2020-05-21	Cowan Gregory L	Sell	11 112	Ordinary Shares
2020-01-28	Schaub James	Sell	9 197	Ordinary Shares
2019-01-24	Weiss Fred G	Buy	34 403	Ordinary Shares

INSIDER POWER
0.00
Last 6 transactions
Buy: 177 968 \| Sell: 29 914

Volumen Korrelation

Lang: -0.10 (neutral)

Kurz: 0.02 (neutral)

Signal:(45.447) Neutral

Osmotica Pharmaceuticals Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Osmotica Pharmaceuticals Korrelation - Währung/Rohstoff

0.42
( neutral )

-0.49
( neutral )

0.00
( neutral )

0.03
( neutral )

-0.74
( moderate negative )

-0.46
( neutral )

Osmotica Pharmaceuticals Finanzdaten

Annual	2022
Umsatz:	$49.72M
Bruttogewinn:	$40.27M (80.98 %)
EPS:	$-0.580

FY	2022
Umsatz:	$49.72M
Bruttogewinn:	$40.27M (80.98 %)
EPS:	$-0.580

FY	2020
Umsatz:	$177.88M
Bruttogewinn:	$103.40M (58.13 %)
EPS:	$-1.520

FY	2019
Umsatz:	$240.03M
Bruttogewinn:	$128.40M (53.49 %)
EPS:	$-5.17

Financial Reports:

No articles found.

Osmotica Pharmaceuticals

Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine extended-release tablet for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adults; Arbaclofen extended-release tablets which is in phase III clinical trial for the treatment of multiple sclerosis spasticity; Upneeq, an oxymetazoline hydrochloride ophthalmic solution for the treatment of Blepharoptosis; and OS870 which is in Phase I clinical trial for the treatment of neurodegenerative disorders. It also provides women's health products, including Divigel for menopause; and OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods. In addition, the company's non-promoted products comprise methylphenidate ER tablets for ADHD; venlafaxine ER tablets to treat major depressive disorders and social anxiety disorders; hydromorphone ER for treating pain; nifedipine ER for hypertension; sodium benzoate/sodium phenylacetate for the treatment of hyperammonemia; oxybutynin ER for overactive bladder; prescription prenatal vitamins for treating nutritional requirements during pregnancy; Lorzone, an immediate-release form of chlorzoxazone indicated for the treatment of acute musculoskeletal pain in conjunction with rest and physical therapy; ConZip, a tramadol hydrochloride for the management of pain; and nitrofurantoin for the treatment of urinary tract infections, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.